Strategy; Cost-Cutting in the Pharmaceutical Industry The pharmaceutical manufacturer Valeant has a business model of cost-cutting, minimizing expenditures on research and delaying clinical trials. The model has succeeded, as Valeant has become one of the largest pharmaceutical companies in the world, with a market capitalization of $41 billion.
Required What type of competitive strategy does Valeant employ? Is this strategy sustainable?
We need at least 10 more requests to produce the solution.
0 / 10 have requested this problem solution
The more requests, the faster the answer.